Development and Manufacturing Challenges for Biologics – MaRS Future of Medicine Series February 8, 2013 RICCentre Seminar: Part of the MaRS Future of Medicine™ Series Topic: Development and Manufacturing Challenges for Biologics When: February 13, 2013 12:00 pm to 1:00 pm Where: MaRS Centre, Studio (Lower Concourse) 101 College Street Toronto, ON Come learn about the stages of drug development from someone who has seen it all. As a contract development and manufacturing organization (CDMO) with its own innovation pipeline, Therapure Biopharma has a unique perspective on growing a business in the life sciences industry. David Bell, VP Drug Development & CSO, will share his experiences in drug development at Therapure, with lessons for researchers and entrepreneurs alike. The monthly MaRS Future of Medicine™ Series is a vibrant forum for sharing experiences and best practices relating to drug and device development. Each event consists of a 30 minute presentation followed by an opportunity for interactive discussion. Since 2006, the MaRS Future of Medicine™ Series has covered a wide range of important topics ranging all the way from structure-based drug discovery to reimbursement. MaRS Future of Medicine™ Series is a must-attend event for anyone engaged in translational research or commercial development within the life sciences.